ArticleJournal of hematology & oncology2017

A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.

Marzia Vezzalini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.